Aug 02, 2015 at 15:33 | Source: PTI
The company has decided to create a new greenfield manufacturing site at Vemgal near Bengaluru, to be operational by 2017.
Jul 14, 2015 at 07:45 | Source: PTI
The FIPB meeting, chaired by Finance Secretary Rajiv Mehirshi, today considered 47 foreign investment proposals. Besides Bandhan and Catholic Syrian Bank, the proposals, which were cleared include GSK Pharma, Mylan Laboratories and Den Networks, sources said.
Jun 09, 2015 at 08:13 | Source: CNBC-TV18
ITC | HUL | Hero Motocorp | HDFC | HDFC Bank | Indian Bank | Tata Steel | Vedanta | Unitech | Jet Airways | Clariant Chemicals | Shasun Pharma | GSK Pharma and Pincon Spirit are stocks, which are in the news today.
Jun 08, 2015 at 14:55 | Source: Moneycontrol.com
Shares of GlaxoSmithKline Pharma and Sanofi slipped 1-2 percent intraday Monday after Competition Commission of India (CCI) has slapped a penalty of Rs 64 crore on drugmakers.
Jun 08, 2015 at 08:01 | Source: CNBC-TV18
Reliance Power | Eros International | Bombay Dyeing | Rural Electrification Corporation | Kotak Mahindra Bank | Bharat Electronics | ONGC | IOC | GlaxoSmithKline Pharma | Nestle India | Wockhardt | YES Bank and Emkay Global are stocks, which are in the news today.
Mar 03, 2015 at 10:45 | Source: PTI
"GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries on Tuesday announced that their respective wholly owned subsidiaries have reached an agreement related to GSK's Opiates business in Australia," the companies said in a joint statement.
Mar 03, 2015 at 09:00 | Source: CNBC-TV18
The transaction is expected to close by August 2015.
Mar 03, 2015 at 08:27 | Source: Moneycontrol.com
GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries today announced that their respective wholly owned subsidiaries have reached an agreement related to GSKs Opiates business in Australia.
Feb 12, 2015 at 20:56 | Source: PTI
"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the BSE.
Feb 12, 2015 at 14:13 | Source: Moneycontrol.com
Its EBITDA was flat at Rs 115 crore versus Rs 118 crore.